Thromboinflammatory response in SARS-CoV-2 sepsis

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Viral sepsis is rare, and its real incidence is not known. SARS-CoV-2 infection causes the release of a significant amount of pro-inflammatory cytokines that aggravates interstitial pneumonia and evolves in viral sepsis with prominent hypercoagulability. We believe it is useful and advisable to establish early immunomodulator therapy and the prophylaxis anticoagulant therapy should be rethought.

Related collections

Author and article information

Journal

Title: Medico-Legal Journal

Abbreviated Title: Med Leg J

Publisher: SAGE Publications

ISSN (Print): 0025-8172

ISSN (Electronic): 2042-1834

Publication date Created: July 2020

Publication date (Electronic): June 03 2020

Publication date (Print): July 2020

Volume: 88

Issue: 2

Pages: 78-80

Affiliations

[1 ]Department of Surgical Pathology, Medical, Molecular and Critical Area, Institute of Legal Medicine, University of Pisa, Pisa, Italy

[2 ]Gemelli IRCCS Research Hospital, Fondazione Policlinico Universitario A. Rome, Italy

[3 ]Department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Sapienza University of Rome, Rome, Italy

Article

DOI: 10.1177/0025817220926915

PubMed ID: 32490726

SO-VID: ec9a4ec1-7e45-4f37-aa71-4c6f57e3f859

License:

http://journals.sagepub.com/page/policies/text-and-data-mining-license

History

Data availability:

Comments

Comment on this article

scite_

Cited by 15

See all cited by